Synergy Innovation Competitors and Similar CompaniesClear all

Synergy Innovation's competitors and similar companies include Abbott India, Precise Group, Guangxi Wuzhou Zhongheng and Lichtenheldt.

	Synergy Innovation Synergy Innovation is a drug development company.	Abbott India Abbott India is a pharmaceutical company that offers medicinal drugs.	Precise Group Precise is a company that manufactures drugs.	Guangxi Wuzhou Zhongheng Guangxi Wuzhou Zhongheng (广西中恒集团) is a company that manufactures pharmaceuticals and food production.	Lichtenheldt Lichtenheldt is a company that manufactures medicines, cosmetics, disinfectants, and dietary supplements.
Founding Date	Founding Date 1999	Founding Date 1944	Founding Date 1997	Founding Date 1993	Founding Date 1745
Type	Type Public	Type Public	Type Private	Type Public	Type Private
Tags	Tags Manufacturing & Industrial drug development medical devices pharma	Tags Manufacturing & Industrial drug development medical devices pharma pharmacy	Tags Manufacturing & Industrial drug development medical devices pharma	Tags Manufacturing & Industrial consumer products & services drug development medical devices pharma	Tags Healthcare cosmetics drug development pharma
Locations	Locations Seongnam, KR HQ	Locations Mumbai, IN HQ Mumbai, IN Verna, IN	Locations Mumbai, IN HQ Dindori, IN Jhalawar, IN Mumbai, IN Navi Mumbai, IN Navi Mumbai, IN	Locations Wuzhou, CN HQ	Locations Wahlstedt, DE HQ Wahlstedt, DE
Employees	Employees N/A	Employees 3,814	Employees 5	Employees 2,971	Employees 462% increase
Financial
Revenue (est.)	Revenue (est.) ₩113.1b (FY, 2025)	Revenue (est.) ₹69.3b (FY, 2026)	Revenue (est.) N/A	Revenue (est.) ¥1.7b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods ₩60.3b (FY, 2025)	Cost of goods ₹36.9b (FY, 2026)	Cost of goods N/A	Cost of goods ¥977.5m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit ₩53.4b (FY, 2025)	Gross profit ₹35.2b (FY, 2026)	Gross profit N/A	Gross profit ¥733.1m (FY, 2025)	Gross profit €23m (FY, 2020)
Net income	Net income ₩11.2b (FY, 2025)	Net income ₹15.5b (FY, 2026)	Net income N/A	Net income (¥495.3m) (FY, 2025)	Net income €3.1m (FY, 2020)